My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 408

    1.

    Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.

    Rosenson RS, Wolff DA, Huskin AL, Helenowski IB, Rademaker AW.

    Diabetes Care. 2007 Aug;30(8):1945-51. Epub 2007 May 4.PMID: 17483155 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.

    Rosenson RS, Huskin AL, Wolff DA, Helenowski IB, Rademaker AW.

    Atherosclerosis. 2008 Jun;198(2):381-8. Epub 2008 Feb 1.PMID: 18242616 [PubMed - indexed for MEDLINE]Related articles

    3.

    Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.

    Rosenson RS.

    Am Heart J. 2008 Mar;155(3):499.e9-16. Epub 2008 Jan 31.PMID: 18294485 [PubMed - indexed for MEDLINE]Related articles

    4.

    Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.

    Vega GL, Cater NB, Hadizadeh DR 3rd, Meguro S, Grundy SM.

    Clin Pharmacol Ther. 2003 Sep;74(3):236-44.PMID: 12966367 [PubMed - indexed for MEDLINE]Related articles

    5.

    Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.

    Davidson MH, Bays H, Rhyne J, Stein E, Rotenberg K, Doyle R.

    Clin Ther. 2005 Jun;27(6):715-27.PMID: 16117978 [PubMed - indexed for MEDLINE]Related articles

    6.

    Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia.

    Koh KK, Han SH, Quon MJ, Yeal Ahn J, Shin EK.

    Diabetes Care. 2005 Jun;28(6):1419-24.PMID: 15920062 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.

    Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG.

    Diabetes. 2003 Mar;52(3):803-11.PMID: 12606523 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia.

    Capell WH, DeSouza CA, Poirier P, Bell ML, Stauffer BL, Weil KM, Hernandez TL, Eckel RH.

    Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):307-13.PMID: 12588776 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.

    Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, Riccardi G.

    Diabetes Care. 1996 Nov;19(11):1207-13.PMID: 8908381 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of fenofibrate on endothelial function and cell adhesion molecules during post-prandial lipemia in hypertriglyceridemia.

    Marchesi S, Lupattelli G, Lombardini R, Roscini AR, Siepi D, Vaudo G, Pirro M, Sinzinger H, Schillaci G, Mannarino E.

    J Clin Pharm Ther. 2003 Oct;28(5):419-24.PMID: 14632967 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.

    Genest J Jr, Nguyen NH, Theroux P, Davignon J, Cohn JS.

    J Cardiovasc Pharmacol. 2000 Jan;35(1):164-72.PMID: 10630748 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment.

    Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Esposito K, Giugliano D.

    Diabetes. 2004 Mar;53(3):701-10.PMID: 14988255 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.

    Kelley DS, Siegel D, Vemuri M, Mackey BE.

    Am J Clin Nutr. 2007 Aug;86(2):324-33.PMID: 17684201 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.

    Rosenson RS.

    Obesity (Silver Spring). 2009 Mar;17(3):504-9. Epub 2008 Nov 20.PMID: 19023279 [PubMed - indexed for MEDLINE]Related articles

    15.

    Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.

    Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Kim JA, Lee Y, Shin EK.

    Diabetes Care. 2006 Feb;29(2):195-201.PMID: 16443859 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.

    Vega GL, Ma PT, Cater NB, Filipchuk N, Meguro S, Garcia-Garcia AB, Grundy SM.

    Am J Cardiol. 2003 Apr 15;91(8):956-60.PMID: 12686335 [PubMed - indexed for MEDLINE]Related articles

    17.

    Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.

    Chan DC, Watts GF, Ooi EM, Ji J, Johnson AG, Barrett PH.

    Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1831-7. Epub 2008 Jun 19.PMID: 18566295 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.

    Boquist S, Ruotolo G, Hellénius ML, Danell-Toverud K, Karpe F, Hamsten A.

    Atherosclerosis. 1998 Apr;137(2):391-400.PMID: 9622282 [PubMed - indexed for MEDLINE]Related articles

    19.

    Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults.

    Badiou S, Merle De Boever C, Dupuy AM, Baillat V, Cristol JP, Reynes J.

    Atherosclerosis. 2004 Feb;172(2):273-9.PMID: 15019537 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals.

    Giacco R, Clemente G, Luongo D, Lasorella G, Fiume I, Brouns F, Bornet F, Patti L, Cipriano P, Rivellese AA, Riccardi G.

    Clin Nutr. 2004 Jun;23(3):331-40.PMID: 15158296 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity